Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safe, Timely Antithrombotic Removal-Ticagrelor (STAR-T): Double-blind Randomized Study of Reduction in Bleeding by Ticagrelor Removal Via Intraop Use of DrugSorb-Antithrombotic Removal (ATR) in Cardiac Surgery Patients <2 Days of Drug Stop

NCT04976530 is registered in ClinicalTrials.gov with CytoSorbents, Inc as lead sponsor.

NCT NCT04976530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safe, Timely Antithrombotic Removal-Ticagrelor (STAR-T): Double-blind Randomized Study of Reduction in Bleeding by Ticagrelor Removal Via Intraop Use of DrugSorb-Antithrombotic Removal (ATR) in Cardiac Surgery Patients <2 Days of Drug Stop
Lead sponsor
CytoSorbents, Inc
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2021
Completion date
August 7, 2023
Enrollment
140 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, postoperative, blood loss, surgical, hemorrhage postoperative, hemorrhage, surgical